n-methylaspartate has been researched along with Magnesium Deficiency in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glick, JL; McMillan, PA | 1 |
| Eby, GA; Eby, KL | 1 |
| Agnani, G; Bac, P; Delplanque, B; Durlach, J; German-Fattal, M; Maurois, P; Pages, N; Poupaert, J; Vamecq, J | 1 |
| Bardgett, ME; McGill, DL; Richmond, RE; Schultheis, PJ; Wagge, JR | 1 |
| Behr, J; Heinemann, U; Solger, J | 1 |
| Attkisson, E; Blair, RE; DeLorenzo, RJ; Deshpande, LS; Lou, JK; Mian, A; Sombati, S | 1 |
| Godukhin, OV; Sem'ianov, AV | 1 |
| Bac, P; Delcourt, P; Herrenknecht, C; Maurois, P; Stables, JP; Vamecq, J | 1 |
| Poulain, P | 1 |
| Aram, JA; Lodge, D | 1 |
1 review(s) available for n-methylaspartate and Magnesium Deficiency
| Article | Year |
|---|---|
Magnesium for treatment-resistant depression: a review and hypothesis.
Topics: Animals; Antidepressive Agents, Tricyclic; Brain; Clinical Trials as Topic; D-Aspartic Acid; Depression; Depressive Disorder; Depressive Disorder, Major; Fast Foods; Humans; Imipramine; Magnesium; Magnesium Deficiency; Mental Disorders; Models, Neurological; N-Methylaspartate; Randomized Controlled Trials as Topic; Suicide, Attempted | 2010 |
9 other study(ies) available for n-methylaspartate and Magnesium Deficiency
| Article | Year |
|---|---|
A multipronged, nutritional-based strategy for managing Alzheimer's disease.
Topics: Aged; Albumins; Aluminum; Alzheimer Disease; Amyloid beta-Peptides; Animals; Atrophy; Blood-Brain Barrier; Brain; Carbohydrate Metabolism; Diabetes Mellitus; Dietary Supplements; Gray Matter; Homocysteine; Humans; Learning; Magnesium; Magnesium Deficiency; Memory; Middle Aged; Models, Theoretical; N-Methylaspartate; Nutritional Sciences; Plasma Exchange; Rats; Silicic Acid; Vitamin B Complex | 2016 |
Threshold to N-methyl-D-aspartate-induced seizures in mice undergoing chronic nutritional magnesium deprivation is lowered in a way partly responsive to acute magnesium and antioxidant administrations.
Topics: Acoustic Stimulation; Animals; Antioxidants; Azoles; Dose-Response Relationship, Drug; Isoindoles; Magnesium; Magnesium Deficiency; Mice; N-Methylaspartate; Organoselenium Compounds; Seizures | 2009 |
Magnesium deficiency impairs fear conditioning in mice.
Topics: Animals; Conditioning, Classical; Exploratory Behavior; Fear; Magnesium; Magnesium Deficiency; Male; Mice; Mice, Inbred C57BL; Motor Activity; N-Methylaspartate; Pain Threshold; Receptors, N-Methyl-D-Aspartate; Seizures | 2005 |
Electrical and chemical long-term depression do not attenuate low-Mg2+-induced epileptiform activity in the entorhinal cortex.
Topics: Animals; Disease Models, Animal; Electric Stimulation; Electric Stimulation Therapy; Entorhinal Cortex; Epilepsy; Humans; In Vitro Techniques; Long-Term Potentiation; Long-Term Synaptic Depression; Magnesium Deficiency; Mice; N-Methylaspartate; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Seizures | 2005 |
Time course and mechanism of hippocampal neuronal death in an in vitro model of status epilepticus: role of NMDA receptor activation and NMDA dependent calcium entry.
Topics: Animals; Calcium; Calcium Signaling; Cell Death; Cells, Cultured; Data Interpretation, Statistical; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Hippocampus; Magnesium Deficiency; N-Methylaspartate; Neurons; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Seizures; Status Epilepticus; Stroke | 2008 |
[Long-lasting reduction of the threshold of epileptiform discharges induced by periodic removal of extracellular Mg2+ in slices of CA1 field of the rat hippocampus].
Topics: Action Potentials; Animals; Calcium Channels; Calcium Channels, L-Type; Electrophysiology; Epilepsy; Extracellular Space; Hippocampus; In Vitro Techniques; Magnesium Deficiency; N-Methylaspartate; Rats | 1998 |
Synthesis and anticonvulsant and neurotoxic properties of substituted N-phenyl derivatives of the phthalimide pharmacophore.
Topics: Administration, Oral; Animals; Anticonvulsants; Batrachotoxins; Cerebral Cortex; Convulsants; Electroshock; Excitatory Amino Acid Agonists; gamma-Aminobutyric Acid; In Vitro Techniques; Ion Channel Gating; Kainic Acid; Magnesium Deficiency; Mice; N-Methylaspartate; Patch-Clamp Techniques; Pentylenetetrazole; Phenytoin; Phthalimides; Rats; Seizures; Sodium Channel Blockers; Structure-Activity Relationship; Synaptosomes; Tumor Cells, Cultured | 2000 |
Two distinct types of repetitive bursting activity mediated by NMDA in hypothalamic neurons in vitro.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Extracellular Space; Female; Glutamic Acid; Guinea Pigs; Hypothalamus; Magnesium Deficiency; N-Methylaspartate; Neurons; Nickel; Organ Culture Techniques; Patch-Clamp Techniques; Periodicity; Potassium Channel Blockers; Potassium Channels; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; Tetrodotoxin | 2001 |
Epileptiform activity induced by alkalosis in rat neocortical slices: block by antagonists of N-methyl-D-aspartate.
Topics: 2-Amino-5-phosphonovalerate; Alkalosis; Animals; Aspartic Acid; Cerebral Cortex; Epilepsy; In Vitro Techniques; Ketamine; Magnesium Deficiency; N-Methylaspartate; Rats; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Valine | 1987 |